an increase in the placebo group.117 Results from the PIONEER program demonstrate that oral semaglutide is effective, safe, and well tolerated for glycemic control in patients with DM2, including those with DKD, with the specific benefits of this family of drugs
Having moderate to severe diabetic retinopathy before starting the medication A history of poorly controlled blood sugar over many years High blood pressure that is not well managed Kidney disease or other diabetes-related complications Very rapid reduction in hemoglobin A1C levels within the first few months Rare cases of sudden, painless vision loss from optic nerve injury have been reported in people using GLP-1 receptor agonists
Here are a few things that can influence how fast semaglutide works: Your dosage and how its increased: A slower increase means fewer side effects, but it may also result in slower appetite control
Decrease in lung inflammation is why GLP-1 meds work for asthma patients In a fun twist, that is beyond the scope of this post but worth mentioning, in the rodent models lacking GLP-1R in the brain were given tirzepatide, a GLP-1 & GIP agonist, then some of the anti-inflammatory benefits returned, suggesting GIP has an anti-inflammatory role as well
The slowed digestion